Culture adaptation of embryonic stem cells echoes germ cell malignancy

被引:47
作者
Harrison, Neil J.
Baker, Duncan
Andrews, Peter W.
机构
[1] Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
[3] Sheffield Childrens Trust, N Trent Clin Cytogenet Serv, Sheffield, S Yorkshire, England
来源
INTERNATIONAL JOURNAL OF ANDROLOGY | 2007年 / 30卷 / 04期
基金
英国医学研究理事会;
关键词
culture adaptation; embryonic stem cell; genetic transformation; germ cell tumour;
D O I
10.1111/j.1365-2605.2007.00762.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Teratocarcinomas are a subset of tumours that result from the neoplastic transformation of primordial germ cells. Such germ cell tumours (GCT) are histologically heterogeneous, reflecting a capacity for differentiation (pluripotency) of their embryonal carcinoma (EC) stem cells. However, malignant evolution of these tumours may ultimately correlate with a decrease in pluripotency, because this would tend to increase the propensity of EC cells for self-renewal. Human embryonic stem (ES) cells, derived from early blastocysts, closely resemble EC cells and, on prolonged culture in vitro, acquire progressive genetic changes that show striking similarity to those seen in GCT (e.g. gain of material from chromosome 12). In parallel, these abnormal ES cells show enhanced population growth rates and plating efficiencies, indicative of their adaptation to culture conditions. Understanding the mechanisms that drive such culture adaptation of ES cells may also provide insights into the development and progression of GCT.
引用
收藏
页码:275 / 281
页数:7
相关论文
共 55 条
  • [11] Molecular biology in acute leukemia
    Camós M.
    Colomer D.
    [J]. Clinical and Translational Oncology, 2006, 8 (8) : 550 - 559
  • [12] DAMJANOV I, 1990, CANCER SURV, V9, P303
  • [13] Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
    Draper, JS
    Smith, K
    Gokhale, P
    Moore, HD
    Maltby, E
    Johnson, J
    Meisner, L
    Zwaka, TP
    Thomson, JA
    Andrews, PW
    [J]. NATURE BIOTECHNOLOGY, 2004, 22 (01) : 53 - 54
  • [14] Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: Partial retention of a pluripotent phenotype
    Duran, C
    Talley, PJ
    Walsh, J
    Pigott, C
    Morton, IE
    Andrews, PW
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (03) : 324 - 332
  • [15] Growing evidence that several human cancers may originate in utero
    Ekbom, A
    [J]. SEMINARS IN CANCER BIOLOGY, 1998, 8 (04) : 237 - 244
  • [16] Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells
    Enver, T
    Soneji, S
    Joshi, C
    Brown, J
    Iborra, F
    Orntoft, T
    Thykjaer, T
    Maltby, E
    Smith, K
    Abu Dawud, R
    Jones, M
    Matin, M
    Gokhale, P
    Draper, J
    Andrews, PW
    [J]. HUMAN MOLECULAR GENETICS, 2005, 14 (21) : 3129 - 3140
  • [17] ESTABLISHMENT IN CULTURE OF PLURIPOTENTIAL CELLS FROM MOUSE EMBRYOS
    EVANS, MJ
    KAUFMAN, MH
    [J]. NATURE, 1981, 292 (5819) : 154 - 156
  • [18] Caught up in a Wnt storm: Wnt signaling in cancer
    Giles, RH
    van Es, JH
    Clevers, H
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2003, 1653 (01): : 1 - 24
  • [19] RISK-FACTORS FOR CANCER OF THE TESTIS IN YOUNG MEN
    HENDERSON, BE
    BENTON, B
    JING, J
    YU, MC
    PIKE, MC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1979, 23 (05) : 598 - 602
  • [20] CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells
    Herszfeld, D
    Wolvetang, E
    Langton-Bunker, E
    Chung, TL
    Filipczyk, AA
    Houssami, S
    Jamshidi, P
    Koh, K
    Laslett, AL
    Michalska, A
    Nguyen, L
    Reubinoff, BE
    Tellis, I
    Auerbach, JM
    Ording, CJ
    Looijenga, LHJ
    Pera, MF
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (03) : 351 - 357